Entero Healthcare Reports Q2 FY27 Results and Approves Fresh ESOP Grant
Entero Healthcare Solutions Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 2:00 am
Entero Healthcare Reports Q2 FY27 Results and Approves Fresh ESOP Grant Entero Healthcare Solutions reported consolidated revenue from operations of Rs 20,870.75m for the quarter ended 30th Sep'26, up 32.9% YoY from Rs 15,709.48m. Consolidated net profit rose 65.96% YoY to Rs 607.42m against Rs 366.00m, with basic EPS reaching Rs 10.47. For H1 FY27, consolidated revenue stood at Rs 40,275.70m with a net profit of Rs 1,127.93m. Additionally, the Board noted the grant of 49,712 fresh employee stock options under its ESOP Plan 2023 at an exercise price of Rs 804 per share.
Original exchange filing (PDF)
More announcements from Entero Healthcare Solutions Ltd
- Transcript of Earnings Call / Conference Call 路 13 Nov 2026
- Recording of Earnings Call/ Conference Call on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for 3P India Equity Fund 路 05 Nov 2026
- Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 路 05 Nov 2026
- Investor Presentation on Unaudited Financial Results for the quarter and half year ended September 30, 2026 路 05 Nov 2026
- Entero Healthcare Solutions Limited has informed the Exchange regarding Grant of 49712 Options. 路 05 Nov 2026
- Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 05 Nov 2026
- Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
